Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure-Reference-Cited by-同舟云学术

Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure

Published:2023-11 Issue:11 Volume:11 Page:1507-1517
ISSN:2213-1779
Container-title:JACC: Heart Failure
language:en
Short-container-title:JACC: Heart Failure

Author:

Khan Muhammad Shahzeb,Singh Sumitabh,Segar Matthew W.,Usman Muhammad Shariq,Keshvani Neil^ORCID,Ambrosy Andrew P.,Fiuzat Mona,Van Spall Harriette G.C.^ORCID,Fonarow Gregg C.^ORCID,Zannad Faiez^ORCID,Felker G. Michael,Januzzi James L.,O’Connor Christopher,Butler Javed,Pandey Ambarish

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. 2022 AHA/ACC/HFSA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines;Heidenreich;J Am Coll Cardiol,2022

2. Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised trial;Mebazaa;Lancet,2022

3. Quadruple medical therapy for heart failure: medications working together to provide the best care;Greene;J Am Coll Cardiol,2021

4. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry;Greene;J Am Coll Cardiol,2018

5. Mineralocorticoid receptor antagonist use after hospitalization of patients with heart failure and post-discharge outcomes: a single-center retrospective cohort study;Durstenfeld;BMC Cardiovasc Disord,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypharmacy and Guideline-Directed Medical Therapy Initiation Among Adults Hospitalized With Heart Failure;JACC: Advances;2024-09

2. Digital solutions to optimize guideline-directed medical therapy prescription rates in patients with heart failure: a clinical consensus statement from the ESC Working Group on e-Cardiology, the Heart Failure Association of the European Society of Cardiology, the Association of Cardiovascular Nursing & Allied Professions of the European Society of Cardiology, the ESC Digital Health Committee, the ESC Council of Cardio-Oncology, and the ESC Patient Forum;European Heart Journal - Digital Health;2024-08-30

3. Uptake of SGLT2i and Outcomes in Patients with Diabetes and Heart Failure: A Population-Based Cohort and a Specialized Clinic Cohort;American Heart Journal;2024-08

4. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Hospitalized Patients;JACC: Advances;2024-07

5. Effects of sacubitril/valsartan according to polypharmacy status in PARAGON‐HF;European Journal of Heart Failure;2024-04-08